Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like Zacks Profit Secrets: Low-Risk Strategy Produces 127% Average Return Sharkninja (SN) and Columbia Sportswear (COLM): 6/27/25 Bull & Bear Monitoring The Cape Ratio: Are Stocks Overvalued, Or Will The Bull Run Continue?